Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company AbbVie Inc.
DescriptionAntibody-drug conjugate (ADC) composed of humanized anti-protein tyrosine kinase 7 (PTK7; CCK4) antibody linked to an auristatin
Molecular Target Protein tyrosine kinase 7 (PTK7) (CCK4)
Mechanism of ActionAntibody-drug conjugate
Therapeutic ModalityBiologic: Antibody-drug conjugate
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat advanced solid tumors
Regulatory Designation
PartnerPfizer Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today